{
    "2019-06-12": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Roche's Rituxan Gets Priority Review for Blood Disorder",
                "features": {
                    "keywords": [
                        "Rituxan",
                        "Priority Review",
                        "Blood Disorder"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Novartis Reports Data on Cosentyx for Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cosentyx",
                        "Psoriatic Arthritis",
                        "Data"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}